Erica M. Gomes

Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

Richard P. Junghans, Qiangzhong Ma, Ritesh Rathore et al. · The Prostate · 2016 · 265 citations

Medicine, Immunology, Oncology +17

Second-Generation Anti–Carcinoembryonic Antigen Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor Activity <i>In vivo</i> : A Preclinical Evaluation

Peter Emtage, Agnes S. Lo, Erica M. Gomes et al. · Clinical Cancer Research · 2008 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells

Erica M. Gomes, Margret S. Rodrigues, Anagha P. Phadke et al. · Clinical Cancer Research · 2009 · 67 citations

Medicine, Cancer Biology, Oncology +10

Advanced generation anti‐prostate specific membrane antigen designer T Cells for prostate cancer immunotherapy

Qiangzhong Ma, Erica M. Gomes, Agnes S. Lo et al. · The Prostate · 2013 · 50 citations

Life Sciences, Immunology, Oncology +17

Cell Density Plays a Critical Role in Ex Vivo Expansion of T Cells for Adoptive Immunotherapy

Qiangzhong Ma, Ya‐Wen Wang, Agnes S. Lo et al. · Journal of Biomedicine and Biotechnology · 2010 · 48 citations · Full text

Life Sciences, Cell Biology, Immunology +17